Jerónimo Martins, a Portugal-based grocer with strong Polish market exposure, is still rated as a 'BUY' at €17.9 per share. However, the price target has been lowered to €18.5 due to slower-than-expected earnings growth despite operational improvements like margin recovery and strong volume growth in key segments. Earnings per share remain weak due to deflation and high capital expenditures. The valuation now assumes normalized earnings of €1.25 per share with a fair price-to-earnings ratio of 14–14.5x, reflecting increased forecast uncertainty. The stock offers an attractive risk/reward profile below €16 per share but upside potential is more moderate and depends on operational improvements.
BDR Pharmaceuticals has filed a lawsuit against the FDA, disputing the agency's refusal to accept an abbreviated new drug application referencing Phathom Pharmaceuticals' VOQUEZNA. BDR claims the FDA wrongly extended Phathom's exclusivity period unde...
Ipsos achieved 2.0% organic revenue growth in Q3 2026, up from 0.8% in H1, driven by strong performances in EMEA, China, and citizen-related activities. The company updated its 2026 organic growth target to 1.2%-1.5%, reflecting improved momentum and...
Ipsos posted €636.2 million revenue in Q3 2026 with 2.0% organic growth, up from 0.8% in H1, led by strong performances in EMEA, China, and its Citizens business. The company updated its full-year organic growth outlook to 1.2%-1.5%, citing ongoing g...
Signify reported third-quarter 2026 results with sales of EUR 1,367 million, a slight decline in comparable sales by 3.4%, but improved adjusted EBITA of EUR 145 million and a margin increase to 10.6%. Net income rose to EUR 88 million and free cash ...
Bitcoin fell to around $81,331 and Ether dropped below $2,400 on October 22, driven by heavy liquidations of leveraged long positions which accounted for 93.7% of the $221 million total liquidations. Bitcoin liquidations alone reached about $77 milli...
